Back to Authors

Liao, Bing

https://orcid.org/0000-0001-9769-9767

A5040910992 | I1330342723

Mayo Clinic

Citations 5

Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Neurology | June 13, 2024 | Volume: 103 | Issue: 1 | Pages: No page available

10.1212/wnl.0000000000209496 | PMID 38870464

Compound Muscle Action Potential (CMAP) Duration and Myosin Loss in Patients with Critical Illness Myopathy: Correlation and Prognostication (P1-11.005)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205833

Neuromuscular complications occurring in solid tumor cohort treated with PD-1 inhibitors (P6.176)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p6.176

Prolonged Compound Muscle Action Potential Duration and Its Pathological Correlation in Critical Illness Myopathy (P1.112)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p1.112

Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies

JAMA Neurology | September 5, 2017 | Volume: 74 | Issue: 10 | Pages: 1216

10.1001/jamaneurol.2017.1912 | PMID 28873125